Global Measles Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Measles Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Measles Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Measles Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Measles Vaccine Segment by Type

2.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)

2.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

2.3 Measles Vaccine Sales by Type

2.3.1 Global Measles Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Measles Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Measles Vaccine Sale Price by Type (2017-2022)

2.4 Measles Vaccine Segment by Application

2.4.1 Children

2.4.2 Adults

2.5 Measles Vaccine Sales by Application

2.5.1 Global Measles Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Measles Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Measles Vaccine Sale Price by Application (2017-2022)

3 Global Measles Vaccine by Company

3.1 Global Measles Vaccine Breakdown Data by Company

3.1.1 Global Measles Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Measles Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Measles Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Measles Vaccine Revenue by Company (2020-2022)

3.2.2 Global Measles Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Measles Vaccine Sale Price by Company

3.4 Key Manufacturers Measles Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Measles Vaccine Product Location Distribution

3.4.2 Players Measles Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Measles Vaccine by Geographic Region

4.1 World Historic Measles Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Measles Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Measles Vaccine Annual Revenue by Geographic Region

4.2 World Historic Measles Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Measles Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Measles Vaccine Annual Revenue by Country/Region

4.3 Americas Measles Vaccine Sales Growth

4.4 APAC Measles Vaccine Sales Growth

4.5 Europe Measles Vaccine Sales Growth

4.6 Middle East & Africa Measles Vaccine Sales Growth

5 Americas

5.1 Americas Measles Vaccine Sales by Country

5.1.1 Americas Measles Vaccine Sales by Country (2017-2022)

5.1.2 Americas Measles Vaccine Revenue by Country (2017-2022)

5.2 Americas Measles Vaccine Sales by Type

5.3 Americas Measles Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Measles Vaccine Sales by Region

6.1.1 APAC Measles Vaccine Sales by Region (2017-2022)

6.1.2 APAC Measles Vaccine Revenue by Region (2017-2022)

6.2 APAC Measles Vaccine Sales by Type

6.3 APAC Measles Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Measles Vaccine by Country

7.1.1 Europe Measles Vaccine Sales by Country (2017-2022)

7.1.2 Europe Measles Vaccine Revenue by Country (2017-2022)

7.2 Europe Measles Vaccine Sales by Type

7.3 Europe Measles Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Measles Vaccine by Country

8.1.1 Middle East & Africa Measles Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Measles Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Measles Vaccine Sales by Type

8.3 Middle East & Africa Measles Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Measles Vaccine

10.3 Manufacturing Process Analysis of Measles Vaccine

10.4 Industry Chain Structure of Measles Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Measles Vaccine Distributors

11.3 Measles Vaccine Customer

12 World Forecast Review for Measles Vaccine by Geographic Region

12.1 Global Measles Vaccine Market Size Forecast by Region

12.1.1 Global Measles Vaccine Forecast by Region (2023-2028)

12.1.2 Global Measles Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Measles Vaccine Forecast by Type

12.7 Global Measles Vaccine Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Measles Vaccine Product Offered

13.1.3 GSK Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Sanofi-Pasteur

13.2.1 Sanofi-Pasteur Company Information

13.2.2 Sanofi-Pasteur Measles Vaccine Product Offered

13.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi-Pasteur Main Business Overview

13.2.5 Sanofi-Pasteur Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Measles Vaccine Product Offered

13.3.3 Merck Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Novartis

13.4.1 Novartis Company Information

13.4.2 Novartis Measles Vaccine Product Offered

13.4.3 Novartis Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis Main Business Overview

13.4.5 Novartis Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Measles Vaccine Product Offered

13.5.3 Pfizer Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Serum Institute of India

13.6.1 Serum Institute of India Company Information

13.6.2 Serum Institute of India Measles Vaccine Product Offered

13.6.3 Serum Institute of India Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Serum Institute of India Main Business Overview

13.6.5 Serum Institute of India Latest Developments

13.7 China National Biotech Group

13.7.1 China National Biotech Group Company Information

13.7.2 China National Biotech Group Measles Vaccine Product Offered

13.7.3 China National Biotech Group Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 China National Biotech Group Main Business Overview

13.7.5 China National Biotech Group Latest Developments

13.8 Bavarian Nordic

13.8.1 Bavarian Nordic Company Information

13.8.2 Bavarian Nordic Measles Vaccine Product Offered

13.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bavarian Nordic Main Business Overview

13.8.5 Bavarian Nordic Latest Developments

13.9 Emergent Biosolutions

13.9.1 Emergent Biosolutions Company Information

13.9.2 Emergent Biosolutions Measles Vaccine Product Offered

13.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Emergent Biosolutions Main Business Overview

13.9.5 Emergent Biosolutions Latest Developments

13.10 Medimmune

13.10.1 Medimmune Company Information

13.10.2 Medimmune Measles Vaccine Product Offered

13.10.3 Medimmune Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Medimmune Main Business Overview

13.10.5 Medimmune Latest Developments

13.11 Johnson & Johnson

13.11.1 Johnson & Johnson Company Information

13.11.2 Johnson & Johnson Measles Vaccine Product Offered

13.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Johnson & Johnson Main Business Overview

13.11.5 Johnson & Johnson Latest Developments

13.12 CSL Limited

13.12.1 CSL Limited Company Information

13.12.2 CSL Limited Measles Vaccine Product Offered

13.12.3 CSL Limited Measles Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 CSL Limited Main Business Overview

13.12.5 CSL Limited Latest Developments

14 Research Findings and Conclusion

Table 1. Measles Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Measles Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Mumps Measles Rubella Vaccine, Live (MMR-II)

Table 4. Major Players of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Table 5. Global Measles Vaccine Sales by Type (2017-2022) & (K MT)

Table 6. Global Measles Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Measles Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Measles Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Measles Vaccine Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Measles Vaccine Sales by Application (2017-2022) & (K MT)

Table 11. Global Measles Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Measles Vaccine Revenue by Application (2017-2022)

Table 13. Global Measles Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Measles Vaccine Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Measles Vaccine Sales by Company (2020-2022) & (K MT)

Table 16. Global Measles Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Measles Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Measles Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Measles Vaccine Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Measles Vaccine Producing Area Distribution and Sales Area

Table 21. Players Measles Vaccine Products Offered

Table 22. Measles Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Measles Vaccine Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Measles Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Measles Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Measles Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Measles Vaccine Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Measles Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Measles Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Measles Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Measles Vaccine Sales by Country (2017-2022) & (K MT)

Table 34. Americas Measles Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Measles Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Measles Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Measles Vaccine Sales by Type (2017-2022) & (K MT)

Table 38. Americas Measles Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Measles Vaccine Sales by Application (2017-2022) & (K MT)

Table 40. Americas Measles Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Measles Vaccine Sales by Region (2017-2022) & (K MT)

Table 42. APAC Measles Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Measles Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Measles Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Measles Vaccine Sales by Type (2017-2022) & (K MT)

Table 46. APAC Measles Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Measles Vaccine Sales by Application (2017-2022) & (K MT)

Table 48. APAC Measles Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Measles Vaccine Sales by Country (2017-2022) & (K MT)

Table 50. Europe Measles Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Measles Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Measles Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Measles Vaccine Sales by Type (2017-2022) & (K MT)

Table 54. Europe Measles Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Measles Vaccine Sales by Application (2017-2022) & (K MT)

Table 56. Europe Measles Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Measles Vaccine Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Measles Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Measles Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Measles Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Measles Vaccine Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Measles Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Measles Vaccine Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Measles Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Measles Vaccine

Table 66. Key Market Challenges & Risks of Measles Vaccine

Table 67. Key Industry Trends of Measles Vaccine

Table 68. Measles Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Measles Vaccine Distributors List

Table 71. Measles Vaccine Customer List

Table 72. Global Measles Vaccine Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Measles Vaccine Sales Market Forecast by Region

Table 74. Global Measles Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Measles Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Measles Vaccine Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Measles Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Measles Vaccine Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Measles Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Measles Vaccine Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Measles Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Measles Vaccine Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Measles Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Measles Vaccine Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Measles Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Measles Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Measles Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Measles Vaccine Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Measles Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Measles Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Measles Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. GSK Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Measles Vaccine Product Offered

Table 94. GSK Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. Sanofi-Pasteur Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofi-Pasteur Measles Vaccine Product Offered

Table 99. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Sanofi-Pasteur Main Business

Table 101. Sanofi-Pasteur Latest Developments

Table 102. Merck Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Merck Measles Vaccine Product Offered

Table 104. Merck Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Merck Main Business

Table 106. Merck Latest Developments

Table 107. Novartis Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Novartis Measles Vaccine Product Offered

Table 109. Novartis Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Novartis Main Business

Table 111. Novartis Latest Developments

Table 112. Pfizer Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Pfizer Measles Vaccine Product Offered

Table 114. Pfizer Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Pfizer Main Business

Table 116. Pfizer Latest Developments

Table 117. Serum Institute of India Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Serum Institute of India Measles Vaccine Product Offered

Table 119. Serum Institute of India Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Serum Institute of India Main Business

Table 121. Serum Institute of India Latest Developments

Table 122. China National Biotech Group Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. China National Biotech Group Measles Vaccine Product Offered

Table 124. China National Biotech Group Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. China National Biotech Group Main Business

Table 126. China National Biotech Group Latest Developments

Table 127. Bavarian Nordic Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Bavarian Nordic Measles Vaccine Product Offered

Table 129. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Bavarian Nordic Main Business

Table 131. Bavarian Nordic Latest Developments

Table 132. Emergent Biosolutions Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Emergent Biosolutions Measles Vaccine Product Offered

Table 134. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Emergent Biosolutions Main Business

Table 136. Emergent Biosolutions Latest Developments

Table 137. Medimmune Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Medimmune Measles Vaccine Product Offered

Table 139. Medimmune Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Medimmune Main Business

Table 141. Medimmune Latest Developments

Table 142. Johnson & Johnson Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. Johnson & Johnson Measles Vaccine Product Offered

Table 144. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. Johnson & Johnson Main Business

Table 146. Johnson & Johnson Latest Developments

Table 147. CSL Limited Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 148. CSL Limited Measles Vaccine Product Offered

Table 149. CSL Limited Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 150. CSL Limited Main Business

Table 151. CSL Limited Latest Developments

List of Figures

Figure 1. Picture of Measles Vaccine

Figure 2. Measles Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Measles Vaccine Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Measles Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Measles Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Mumps Measles Rubella Vaccine, Live (MMR-II)

Figure 10. Product Picture of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Figure 11. Global Measles Vaccine Sales Market Share by Type in 2021

Figure 12. Global Measles Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Measles Vaccine Consumed in Children

Figure 14. Global Measles Vaccine Market: Children (2017-2022) & (K MT)

Figure 15. Measles Vaccine Consumed in Adults

Figure 16. Global Measles Vaccine Market: Adults (2017-2022) & (K MT)

Figure 17. Global Measles Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Measles Vaccine Revenue Market Share by Application in 2021

Figure 19. Measles Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Measles Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Measles Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Measles Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Measles Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Measles Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Measles Vaccine Sales 2017-2022 (K MT)

Figure 26. Americas Measles Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Measles Vaccine Sales 2017-2022 (K MT)

Figure 28. APAC Measles Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Measles Vaccine Sales 2017-2022 (K MT)

Figure 30. Europe Measles Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Measles Vaccine Sales 2017-2022 (K MT)

Figure 32. Middle East & Africa Measles Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Measles Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Measles Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Measles Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Measles Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Measles Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Measles Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Measles Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Measles Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Measles Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Measles Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Measles Vaccine

Figure 63. Industry Chain Structure of Measles Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles